Biological cell therapies for discogenic low back pain

      Introduction: Biological therapies use the body's natural mechanisms to treat disease. For lower back pain, therapies include a range of increasingly purified and targeted biological products from the blood derived platelet-rich plasma to the more specialised adipose tissue derived and expanded mesenchymal stem cells (MSCs). MSCs have been shown to reduce pain and induce repair in osteoarthritis and disc-related lower back pain. A study of 100 patients showed significant pain relief and improvements 24 months after therapy in patients with chronic lower back pain1 whilst a 10-patient study showed improvements in chronic low back pain as early as three months.2
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic and Personal
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Science and Medicine in Sport
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect